By Ken Buben, President, FancyScrubs.com
C. Difficile Infections
A Massachusetts company Intelligent Medical Devices, Inc., received approval by the European regulators to market their test device for hospital acquired infection C. difficile.
“Our assays are developed to incorporate evolving clinical needs,” IMDx CEO Alice Jacobs said in a written statement. “Early identification of pathogens is critical in improving patient healthcare, shortening hospital stays, and reducing expenses.”
C. difficile or C. diff, is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. Illness from C. difficile most commonly affects older adults in hospitals or in long term care facilities and typically occurs after use of antibiotic medications.
More than three million C. difficile infections occur in hospitals in the US each year.
If you are a healthcare worker be sure to wash your hands properly, clean all instruments properly (Chlorine bleach at a concentration of 1:10 is the only agent that effectively kills C. diff spores on environmental surfaces.) and wear protective medical uniforms to prevent the further spread of this infectious disease.